A detailed history of C2 C Wealth Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, C2 C Wealth Management, LLC holds 790 shares of LLY stock, worth $635,649. This represents 0.61% of its overall portfolio holdings.

Number of Shares
790
Previous 880 10.23%
Holding current value
$635,649
Previous $512,000 19.92%
% of portfolio
0.61%
Previous 0.14%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

SELL
$592.2 - $792.28 $53,298 - $71,305
-90 Reduced 10.23%
790 $614,000
Q4 2023

Feb 13, 2024

SELL
$525.19 - $619.13 $5.41 Million - $6.38 Million
-10,301 Reduced 92.13%
880 $512,000
Q2 2023

Jul 20, 2023

SELL
$350.74 - $468.98 $87,685 - $117,245
-250 Reduced 2.19%
11,181 $5.24 Million
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $26,092 - $30,644
-84 Reduced 0.73%
11,431 $3.93 Million
Q4 2021

Feb 23, 2022

BUY
$224.85 - $279.04 $2.59 Million - $3.21 Million
11,515 New
11,515 $3.18 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $765B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track C2 C Wealth Management, LLC Portfolio

Follow C2 C Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of C2 C Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on C2 C Wealth Management, LLC with notifications on news.